Tag: Head and Neck Cancer
-
Impact of head and neck cancer on the income of Italian employees
Overview: Why income matters for head and neck cancer survivors Head and neck (H&N) cancer presents not only life‑changing medical challenges but also significant economic consequences for workers in Italy. While advances in treatment improve survival, many patients experience reduced earnings due to illness, treatment toxicity, and evolving work capabilities. This article summarizes a comprehensive…
-
The Hidden Cost: How Head and Neck Cancer Kshocks Income for Italian Private-Sector Workers
Introduction: Why income matters for cancer survivors Cancer care has advanced, improving survival and quality of life for many patients. Yet the financial repercussions of diagnosis and treatment can linger long after the tumor is treated. In Italy, where the private sector employs a large share of the workforce, understanding how head and neck (H&N)…
-
Impact of Head and Neck Cancer on the Income of Italian Employees: What the WHIP-Salute Data Reveals
Understanding the Financial Toll of Head and Neck Cancer in Italy Head and neck (H&N) cancer presents significant physical and psychological challenges. Beyond medical treatment, survivors often face ongoing symptoms that affect daily life and work capacity. A growing body of research from Italy’s WHIP-Salute database sheds new light on how a diagnosis can impact…
-
Head and Neck Cancer Breakthrough: A Blood Test Detects Cancer Up to 10 Years Early
Overview: A Potential Turning Point in Cancer Screening Researchers have unveiled a groundbreaking approach that could transform how we screen for head and neck cancers, particularly those linked to the human papillomavirus (HPV). Using a simple blood sample, the new test aims to detect the presence of tumor-derived DNA circulating in the blood (circulating tumor…
-
Head and Neck Cancer: How a Simple Blood Test Can Detect Cancer Up to 10 Years Early
Introduction: A new frontier in cancer screening Imagine having a precautionary tool for cancer, much like a flu vaccine you take before the season. A team of researchers may have brought us a breakthrough that moves us closer to that reality for head and neck cancers. Using a simple blood test, they demonstrated the potential…
-
Head and Neck Cancer: A Simple Blood Test Could Detect Cancer Up to 10 Years Early
A breakthrough in early detection Imagine a future where a routine blood test could reveal a dangerous cancer years before any symptoms appear. That future is closer thanks to a novel blood test that can detect HPV-related head and neck cancers up to ten years before conventional diagnosis. Developed by researchers at Mass General Brigham,…
-
Pembrolizumab Therapy Doubles Survival in Advanced Head and Neck Cancer
Breakthrough Immunotherapy Helps Patients With Locally Advanced Head and Neck Cancer A pivotal advance in the treatment of locally advanced head and neck cancer centers on pembrolizumab, an immunotherapy drug already used in several cancers. In a recent trial, this therapy was integrated into a comprehensive treatment plan that combines surgery, radiotherapy, and chemotherapy, and…
-
Pembrolizumab doubles survival in head and neck cancer: KEYNOTE-689 findings
New hope for locally advanced head and neck cancer: pembrolizumab Locally advanced tumors in the head and neck region pose a formidable challenge. They are often confined to the mucosal areas, yet their proximity to the airway, esophagus, and vital vessels makes surgical removal delicate and potentially mutilating. Radiotherapy and chemotherapy add to the cure…
-
Pembrolizumab Doubles Survival in Advanced Head and Neck Cancer
The Breakthrough: A New Immunotherapy Redefines Outcomes in Locally Advanced Head and Neck Cancer Locally advanced head and neck cancer poses a formidable challenge. In many patients, the disease is detected at a stage where surgery, radiotherapy, and chemotherapy are the mainstays of treatment, yet recurrence and progression remain common. A recent advance in immunotherapy,…
-
Nosebleeds to cancer: A man’s journey
Understanding nasopharyngeal cancer Nasopharyngeal cancer (NPC) is a cancer that originates in the nasopharynx, the upper part of the throat behind the nose. In Singapore, NPC remains one of the more common cancers, with roughly 300 new cases diagnosed each year. While NPC is more prevalent among Chinese men in this country, it does occur…